Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ADENURIC
Active substances:
Febuxostat
Estonian, English, Latin
ATC code: M04AA03
Dosage form: film-coated tablet
Strength: 80mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Indication: Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis). ADENURIC is indicated in adults.
Safety features: Yes
Marketing authorization holder: Menarini International Operations Luxembourg S.A. 
Marketing authorization number: EU/1/08/447 
Marketing authorization issued on: April 21, 2008 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1349287  ADENURIC  film-coated tablet  80mg 28TK  Prescription  90% 100% 75% 50%  7,84  11.04.2024     
1349298  ADENURIC  film-coated tablet  80mg 84TK  Prescription           
1492961  ADENURIC  film-coated tablet  80mg 14TK  Prescription           
1492972  ADENURIC  film-coated tablet  80mg 42TK  Prescription           
1492983  ADENURIC  film-coated tablet  80mg 56TK  Prescription           
1492994  ADENURIC  film-coated tablet  80mg 98TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere